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Abstract 
Strophanthus sarmentosus dc plant seeds are known to be mixed with other plants and boiled to produce poison 
arrow for hunters, it has also been implicated as a medicinal plant for treatment of gonorrhea and Leprosy in 
Senegal. Acute toxicity and minimum parasites inhibitions using four (4) microorganism (proteus, e.coli, 
staphylococcus aureus spp & enterobacter spp)  of the methanolic leaf extract was evaluated in mice using 
Lorke’s & serial dilution methods respectively. The methanolic leaf extract was evaluated for in vivo anti-
trypanosomal activity against federa strain of Trypanosoma brucei brucei in albino mice. Four days suppressive, 
curative effect against established infection and prophylactic models of anti-trypanosomal studies were carried 
out. The median lethal dose of the extract was determined to be ≥ 10mg ⁄ kg body weight. The extract (2.5, 5, 
10mg / kg) exerted some dose dependent suppressive effects at the different levels of infections tested, with no 
significant curative effects recorded. However, further antitrypanosomal property needs to be explored for the 
management of trypanosomiasis.  
Introduction 
African trypanosomiasis is a disease of medical and veterinary importance caused by extracellular 
hemoflagellates of the genus Trypanosoma [Mansfield, J. M. (1981]. Trypanosome-infected hosts are exposed to 
many parasite antigens during the course of infection. These antigens include invariant membrane, cytoplasmic, 
and nuclear antigens as well as a series of distinct, variable surface glycoprotein (VSG) molecules associated 
classically with this infection [,Mansfield, J. M. (1981), Mansfield, J. M. (1990)]. Strophanthus sarmentosus is 
an Apocynaceae plant common in Nigeria and is commonly referred to by some tribes as the following, the 
BEROM hwaàl ndч́m (poisonous medicine), (LB) CHAMBA me-ni , (FNH) EDO ò#víẹn-órà, (Ross) FULA-
FULFULDE (Nigeria) awdi tooke (poisonous seeds) an epithet (JMD) maada (JMD) and tantsiyaari from Hausa 
(JMD). tooke, tookere = poison; the plant, an epithet (JMD) GOEMAI lauenne (JMD) GWARI obwa (JMD) 
HAUSA gama sowa (Ryan) gwasha (FNH) kwaŋkwáníí (LB) tantsiya (JMD; ZOG) IGBO o#ta = a bow (JMD; 
AJC) o#ta nta = a hunting bow (NWT; JMD) TIV àgbùlCf1 (JMD) YORUBA agan olugbo (RJN) akan (RJN) 
ako-isa (Ross) ilagbà o#mo#dé, lãgba-o#mo#de = little child’s horse-whip (Verger; JMD) ire (IFE) is#a 
(Oluakpata; IFE) is#akékeré = lesser (Ross; JMD) sagere (Millen ) (Burkill, H.M. 1985). 
Its Leaf is used as emetics; eye treatments, veneral diseases, analgesic, leprosy, insanity, rheumatism, and 
arthritis, also its known to be used as “arrow-poisons, which incidentally is the most common name for the plant. 
Sleeping sickness in east and southern africa is caused by Trypanosoma brucei rhodesiense and by in west and 
central Africa by Trypanosoma brucei gambiense. Both protozoan species are morphologically indistinguishable, 
but have drastically different epidemiological features. Both are also known to affect the central nervous system. 
According to WHO reports, African sleeping sickness is the third most important contributor to the global 
burden of the parasitic diseases after malaria and schistosomiasis, if the Disability Adjusted Life Year (DALY) 
figures (i.e., loss of healthy life years by premature mortality and disability) are considered [P. Cattand, J. 
Jannin, and P. Lucas,2001]. More than 60 million people are at risk of infection from human African 
trypanosomiasis, with about 45,000 new cases reported annually. It is estimated that at least 300,000–500,000 
people are presently infected. However, less than 4 million people are under surveillance and as such, it is 
estimated that less than 10% of the new cases are diagnosed and treated [WHO(1998)]. 
 
Animal trypanosomiasis is caused by a wider number of trypanosome species and carried with higher prevalence 
by a greater number of glossina species with high vectorial capability, thus invariably the greater epidemic 
across the African continent with direct economic consequences. The epidemiological trend indicates that the 
disease is widespread in 36 sub-Saharan countries for HAT (Human African Trypanosomiasis) and 37 countries 
for AAT (Animal African Trypanosomiasis) covering over 9 million square km between 14 degree north and 20 
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degree south latitude, approximately one third of African’s total land area (NITR Annual Report, 1989; 
Molyneux et al., 1996; Steverding, 2008), trypanosome infections that threaten livestock have a 100 to 150-fold 
higher prevalence than the HAT [A. M. Jordan 1976].About 60 million people and 50 million cattle are at risk of 
being infected with a standing prevalence of 500,000 infections and 66,000 human as well as three (3) million 
livestock deaths occurring annually. Less than 15% of cases in humans are diagnosed and treated (Cecchi and 
Mattioli, 2009; Wellcome Trust, 2005; Kamuanga, 2003; WHO, 2000; Kristjanson, 1999), these above statistical 
analysis should give very ample reason for worry. 
 
Materials and Methods 
The plant was collected and supplied by a cattle rearer at the Ladduga Grazing Reserve in Kachia Local 
Government Area of Kaduna  which is Northwestern zone of Nigeria and was identified at the Herbarium of 
Ahmadu Bello University, Samaru – Zaria, which is in the Northwestern zone of Nigeria with voucher Det: U.S 
Gallah 12/10/2011. All reagents and solvents used were of analytical grade. 
Leaf parts of the plant were harvested dried under the shade or in open air in the laboratory. Dried materials were 
pounded in laboratory mortar into small particles. Fifty grams (50g) of the pounded dried plants materials were 
weighed and extracted with 3 X 150ml methanol (70%) and allowed to macerate for 3 days, then filtered to 
obtain the extract which is then dried under electric fan and stored in a refrigerator at 4oC until required.  
 
Animals 
 
Four (4) weeks old albino mice weighing between 18-20 g obtained from the Animal house of NITR, Kaduna 
were used for the study, they were housed in plastic cages with saw dust as beddings and given food and water 
ad libitum. Acclimatized for two (2) weeks before commencement of research. 
 
Phytochemical Screening 
 
The methanolic stem extract of Strophanthus Sarmentosus dc was screened for the presence of secondary 
metabolites and constituents using conventional protocol for detecting the presence of fatty acids, glycosides, 
triterpenoids and saponins [Anene B.M., Onah D. N., Nawa Y. (2001)]. 
 
Determination of Parasitaemia  
 
Parasitaemia was monitored in blood obtained from the tail, pre-sterilized with methylated spirit. The number of 
parasites was determined microscopically at X 400 magnification using the “Rapid Matching” method of Herbert 
and Lumsden [Ayoola, G.A., F.M. Lawore, T. Adelowotan, et al. (2008)]. Briefly, the method involves 
microscopic counting of parasites per field in pure blood or blood appropriately diluted with phosphate buffer 
saline (PBS, pH 7.2). Logarithm values of these counts obtained by matching with the table of Herbert and 
Lumsden is converted to antilog to provide absolute number of trypanosomes per ml of blood [Hursey, B.S., 
(2001)], [Brun R., Schumacher R., Schmid C., et al. (2001)]. 
 
 
Minimum Inhibition Concentration 
 
Minimum Inhibitory Concentration (MIC) involves the lowest concentration of an antimicrobial that can inhibit 
the visible growth of the microorganism after the overnight incubation. In this case, four (4) common 
microorganism namely, e.coli, enterobacter, staphylococcus aureus app and proteus (fig ii) were subjected to 
inhibition properties with the methanolic stem extract of Strophanthus Sarmentosus dc via serial dilution 
incubation of the extract with each microorganism. 
 
Acute Toxicity Test 
 
Acute toxicity test of Strophanthus Sarmentosus dc stem extract was carried out using the modified Lorke’s 
method [Pepin J. and Meda. H.A.(2001)]. The study was carried in two phases, the first phase requires 9 (nine) 
mice randomized into 3 groups of three mice & each given intraperitoreally 10, 100 & 1000mg/kg body weight 
of the extract. The mice were observed for signs of toxicity which  included but not limited to paw licking, 
salivation, stretching of the body, weakness, sleep, respiratory stress, coma & death in the first four  hours of 
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extract administration and subsequently daily for hours. In the second phase, another fresh set of 9 (nine) mice 
were randomized into 3 groups of three mice again & administered with 1600, 2900 & 500mg/kg of the extract 
intraperitoreally based on the result of the first phase, further observation of signs of toxicity & mortality for the 
first 4 (four) critical hours and daily afterwards. The oral median lethal dose was calculated using the formula: 
LD50 = √ minimum toxic dose x maximum tolerated dose, where the average safe dosage is determined to be 
5mg/kg of mice.  
 
Post Mortem 
 
A post mortem was carried out on expired mice after treatment with the different dosage of strophanthus 
sarmentosus dc extract to determine with organs of the mice where actually affected by the extract and the 
organs photographed. 
 
 
i. Inflammation of the Spleen is observed at 10mg/kg dosage. 
 
ii. The higher the toxicity, the more the inflammation observed in the spleen. 
 
 
iii. Intestines are indicative of extract poisoning. 
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iv. Bladders and testis are indicative of inflammation due to extract. 
In Vivo Assay 
  
Mice inoculated with Trypanosoma brucei brucei (federe strain) were intraperitoreally treated with 5mg/kg body 
weight of the extracts when average parasitaemia was approximately two parasites per field for therapeutic & 
zero parasite per field for prophylactic. Preliminary investigation indicates efficacy with tolerance of extract at 
dosage 1.25mg/kg of mice. The treatment continued daily with continuous monitoring of parasitaemia for 4 
days. After withdrawal of treatment, parasitaemia was also monitored daily until the 5th day and thereafter 
monitoring was reduced for surviving animals. Three animals were used per treatment group. An infected but 
untreated mouse was included as a negative control. 
 
RESULTS 
 
Phytochemical Screening 
 
Results obtained from the phytochemical screening of the methanolic stem extract of Strophanthus Sarmentosus 
dc  revealed the presence of Glycosides and Saponins. 
 
Behavioral signs of toxicity like mobility and sedation was observed in all mice administered with various doses 
and mortality recorded in the first 4 (four) hours at 5mg of extract / kg body weight & total mortality of all mice 
after several hours. The median lethal dose LD50 was determined to be ≥ 100mg / kg body weight. 
 
Table 1. Minimum inhibitory concentration (MIC) of methanolic stem extract of strophanthus 
sarmentosus dc plant. 
NO TEST ORGANISMS STEM 
EXTRACT   ( 
10-1mm) 
0.5ML 
STEM 
EXTRACT 
(10-2) 0.5ML 
STEM 
EXTRACT 
(10-3) 0.5ML 
CONTROL 
(ETHANOL) 
0.5ML 
1 E.COLI - - - - 
2 ENTROBACTER - - - - 
3 PROTEUS - - - - 
4 STAPHYLOCOCCUS 
AUREUS 
- - - - 
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Table 2. Acute toxicity test for Strophanthus Sarmentosus dc methanolic stem extract in albino mice 
Dose (mg/kg)                                  Total mice                                                    Mortality 
10                                                             3                                                                  2 
100                                                           3                                                                  3 
1000                                                         3                                                                  3 
1600                                                         3                                                                  3 
2900                                                         3                                                                  3    
5000                                                         3                                                                  3 
 
 
 
Figure (i). Prophylactic treatment for methanolic stem extract of strophanthus sarmentosus dc plant. 
 
 
 
Figure (ii) Curative treatment for methanolic stem extract of strophanthus sarmentosus dc plant. 
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DISCUSSION 
 
Anti-trypanosomal effect observed under in vivo condition following administration of methanolic stem extracts 
of strophanthus sarmentosus dc (from above graphical representation) is attributable to the extracts, appears to 
be confirmed by the death of all members of the control group that were infected with the parasite but left 
untreated within 4 days of infection, while most survived beyond the 5th days signifying the prophylactic 
properties of the extract whilst for curative treatment parasitaemia was observed to be controlled in the inception 
of treatment but subsequent with little differential. 
The Minimun Inhibition Concentration of the extract against the four microorganism indicated no inhibition on 
all four (4) microorganism tested. 
The phytochemical analysis indicates the presence of glycosides and saponins, with glycosides signifying a 
positive indicator due to its usage in the production of cortisone for treatment of rheumatoid arthritis etc, hence 
its observed trypanosomal activity, saponins on the other hand indicates different. 
The weakness observed in the mice of different groups with continuous administration of the extracts; even after 
parasites were eliminated from the blood stream suggest that the extracts may have some cumulative toxic 
effects at even low dosage as indicative from the inflammations of the spleen, bladder and testis of the mice and 
extremely lethal at high dose as high mortality was observed with dosage of 5mg/kg. Animals were most tolerant 
of dosage of 1.25mg/kg of the extract.  However, put together, these results suggest that Strophanthus 
sarmentosus dc possess significant anti-trypanonosomal effect to warrant further detailed studies utilizing 
bioassay-guided fractionations under varied pharmacological conditions in order to unequivocally establish its 
therapeutic efficacy. 
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